ScoreWhy is RPG Life Sciences Ltd ?
1
High Management Efficiency with a high ROE of 21.33%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 12.37% over the last 5 years
4
Positive results in Dec 24
- NET SALES(Q) Highest at Rs 172.71 cr
- PBDIT(Q) Highest at Rs 49.16 cr.
- OPERATING PROFIT TO NET SALES(Q) Highest at 28.46%
5
Stock is technically in a Mildly Bearish range
- The technical trend has deteriorated from Mildly Bullish on 07-Apr-25 and has generated 2.92% returns since then
- The stocks Bollinger Band and KST technical factors are also Bearish
6
With ROE of 22.9, it has a Fair valuation with a 8.6 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 37.93%, its profits have risen by 2.3% ; the PEG ratio of the company is 16.3
7
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 0.56% over the previous quarter and collectively hold 7.36% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to RPG LifeScience. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is RPG LifeScience. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
RPG LifeScience.
37.36%
0.78
48.84%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.37%
EBIT Growth (5y)
29.40%
EBIT to Interest (avg)
89.78
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.76
Tax Ratio
31.62%
Dividend Payout Ratio
30.18%
Pledged Shares
0
Institutional Holding
7.36%
ROCE (avg)
35.38%
ROE (avg)
21.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
38
Industry P/E
33
Price to Book Value
8.63
EV to EBIT
23.43
EV to EBITDA
20.32
EV to Capital Employed
12.42
EV to Sales
4.94
PEG Ratio
16.32
Dividend Yield
0.81%
ROCE (Latest)
49.08%
ROE (Latest)
22.86%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
NET SALES(Q)
Highest at Rs 172.71 cr
PBDIT(Q)
Highest at Rs 49.16 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 28.46%
PBT LESS OI(Q)
Highest at Rs 43.58 cr.
PAT(Q)
Highest at Rs 34.93 cr.
EPS(Q)
Highest at Rs 21.12
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for RPG LifeScience.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 43.58 cr has Grown at 40.8 %
over average PBT of the previous four quarters of Rs 30.95 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 34.93 cr has Grown at 78.5 %
over average PAT of the previous four quarters of Rs 19.56 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 172.71 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 49.16 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 28.46%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 43.58 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 34.93 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 21.12
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for RPG LifeScience.
Non Operating Income - Quarterly
Highest at Rs 3.31 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
